The immunotherapy drug, durvalumab, has been the norm of care for patients with stage III non-little cell lung cancer(NSCLC) to further develop endurance, when recommended after...
Researchers created a tiny device, about the size of a grain of rice, that can concurrently test a variety of therapies for difficult brain malignancies including...
At age 35, Queen Stewart, a barrister and mother of two, received the diagnosis of breast cancer. Because she was too young for insurance-funded checkups, she...
The expansion of growth getting fields chemotherapy didn’t delay endurance for ladies with platinum-safe ovarian disease, as per the gadget’s maker. Growth treating fields [TTFields (Novocure)]...
According to research that was published by Evernorth Research Institute1, novel immunotherapies hold promise for certain patient groups, but their clinical use remains suboptimal. For instance,...
Two genes, NEK2 and INHBA, have been found to be the root of chemotherapy resistance in patients with head and neck cancer. Surprisingly, cancer cells that...
Every year, 330 women in Colorado receive an ovarian cancer diagnosis, or about one every day. A woman’s life can be saved if she is aware...